Medical Options for Advanced HFpEF/HFmrEF Patients: Patient Cases

Published: 13 August 2024

  • Views:

    Views Icon 2411
  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

Part one of this programme explores two interactive case studies on advanced treatment options for HFpEF and HFmrEF from Prof Pardeep Jhund (University of Glasgow, UK) and Dr Muthiah Vaduganathan (Brigham and Women’s Hospital and Harvard Medical School, US). We encourage you to submit your answers on treatment options in the provided polls.

 

These results will support part two of the programme, An Expert-Guided Virtual Ward Round. In the upcoming live roundtable, leading specialists will analyse the responses, providing detailed insights into prevailing clinical practices and potential areas for improvement. The experts will then share their own perspectives on the presented cases, drawing on their extensive experience and knowledge to offer guidance and recommendations.

 

This programme will support you to stay at the forefront of clinical practice advancements. Join us to enhance your knowledge and improve patient care. Your participation is key – submit your answers today. 

 

Register for part two to join the live discussion.

 

 

 This education was developed by Radcliffe Medical Communications (Eire) Ltd.

This programme is supported by an unrestricted educational grant from Bayer.

Learning Objectives

  • Describe the current limitations of HFmrEF/HFpEF GDMT in advanced patients
  • Select appropriate patients for advanced medical therapy
  • Recall recent trial data for novel therapeutic approaches
  • Use expert guidance to develop an evidence-based approach to managing advanced HFmrEF/HFpEF

Target Audience

  • Cardiologists
  • Internists
  • Heart Failure Specialists
  • General Practitioners
  • Nurse Practitioners
  • Cardiovascular Nurses
  • Allied Healthcare Professionals

More from this programme

Part 1

Case Study

In this video, Prof Pardeep Jhund presents a case study of a patient with preserved ejection fraction and CKD stage 3.

Part 2

Case Study

In this video, Dr Muthiah Vaduganathan presents a case study of a HFpEF patient. 

About the episode

In this video, Prof Pardeep Jhund presents a case study of a patient with preserved ejection fraction and CKD stage 3. Prof Jhund asks, 'How would you treat this patient?'.

Vote in the poll below or via the survey link here.

Faculty Biographies

Pardeep Jhund

Pardeep Jhund

Reader in Cardiology, University of Glasgow

Dr Pardeep Jhund is a Reader in Cardiology at the University of Glasgow, UK.

He trained in medicine at the University of Glasgow, and completed his general medical training in Edinburgh. During this time he also graduated with a MSc in Epidemiology from the London School of Hygiene and Tropical Medicine, London, UK.

Prior to this, he graduated from the University of Glasgow with a PhD in cardiovascular epidemiology, under the tutelage of Prof John McMurray, and completed his fellowship at The Brigham and Women’s Hospital, Boston, US.

Dr Jhund has a special interest in heart failure, around which he has published widely in leading international journals.

View full profile

Comments

You must be to comment. If you are not registered, you can register here.